Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions

3 Feb 2010

Abstract excerpt

BACKGROUND: Screening for colorectal cancer (CRC) has shown to reduce cancer-related mortality, however, acceptance and compliance to current programmes are poor. Developing new, more acceptable non-invasive tests for the detection of cancerous and precancerous colorectal lesions would not only allow preselection of individuals for colonoscopy, but may also prevent cancer by removal of precancerous lesions....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Epigenetics and DNA Methylation
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20140221
DOI: 10.1371/journal.pone.0009061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous LesionsPMID 20140221Read ↗

Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation AssaySemantic proximity Read ↗

Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal CancerSemantic proximity Read ↗

Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detectionSemantic proximity Read ↗

Plasma methylated septin 9: a colorectal cancer screening markerSemantic proximity Read ↗

From Discovery to the Clinic: The Novel DNA Methylation Biomarker <i> <sup>m</sup> </i> SEPT9 For The Detection of Colorectal Cancer in BloodSemantic proximity Read ↗

Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancerSemantic proximity Read ↗

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomasSemantic proximity Read ↗

Detection of colorectal cancer in urine using DNA methylation analysisSemantic proximity Read ↗

Epigenetic Regulation Explains The Functionality Behind Colon Cancer Specific Biomarker Septin9Semantic proximity Read ↗

Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNASemantic proximity Read ↗

DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal CancerSemantic proximity Read ↗

The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.